Skip Ribbon Commands
Skip to main content
Sign In

Quick Launch

 

 Alerts by BEWSD

 
  
  
  
  
  
  
January 2018 - Drugs contaminated with atropine in Belgium and The Netherlands.aspx
  
Blanckaert, Peter22/03/2018 13:43Blanckaert, Peter12/01/2018 15:57
December 2017 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, PeterDecember 2017 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter06/12/2017 23:20Blanckaert, Peter06/12/2017 23:12
July 2017 - Highly dosed MDMA tablets and 2C-B in circulation.aspx
Checked Out To: Blanckaert, PeterJuly 2017 - Highly dosed MDMA tablets and 2C-B in circulation.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter12/07/2017 12:21Blanckaert, Peter12/07/2017 12:07
June 2017 - One death after the consumption of 3-MeO-PCP.aspx
Checked Out To: Blanckaert, PeterJune 2017 - One death after the consumption of 3-MeO-PCP.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter12/07/2017 12:11Blanckaert, Peter12/07/2017 12:08
June 2017 - Highly dosed MDMA tablets and 2C-B in circulation.aspx
Checked Out To: Blanckaert, PeterJune 2017 - Highly dosed MDMA tablets and 2C-B in circulation.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter12/07/2017 12:00Blanckaert, Peter12/07/2017 11:52
May 2017 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, PeterMay 2017 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter12/07/2017 11:26Blanckaert, Peter18/05/2017 10:28
March 2017 - Detection of highly dosed MDMA tablets, MDA and THJ-22011.aspx
Checked Out To: Blanckaert, PeterMarch 2017 - Detection of highly dosed MDMA tablets, MDA and THJ-22011.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter03/04/2017 10:38Blanckaert, Peter29/03/2017 17:24
October 2016 - Detection of 25C-NBOME and a highly dosed MDMA tablet.aspx
  
Antoine, Jerome16/12/2016 08:03Antoine, Jerome27/10/2016 09:06
December 2016 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, PeterDecember 2016 - Highly dosed MDMA tablets in circulation.aspx
Checked Out To: Blanckaert, Peter
  
Blanckaert, Peter14/12/2016 12:36Blanckaert, Peter14/12/2016 12:05
September 2016 - Detection of pCPP and series of highly dosed MDMA tablets.aspx
  
Antoine, Jerome27/10/2016 09:05Antoine, Jerome29/09/2016 10:47
1 - 10Next
 

 Latest news

 
  
  
  
17/01/2018 16:08

On 12 January 2018 the Dutch National Focal Point reported to the EMCDDA that in the last week, atropine has been detected in samples of cocaine and ketamine from North Brabant, Netherlands. In addition, they reported that poisonings suspected to involve atropine have been reported earlier this month in North Brabant and the Rotterdam region [1].

In addition to these reports, the Belgian National Focal Point also reported today that there has been at least three cases in the past week in the Antwerp region of Belgium where atropine was detected in the urine of known cocaine users. The Focal Point reported that atropine has not yet been detected in powder samples in Belgium.

Symptoms of atropine poisoning include: amnesia, disorientation, visual hallucinations, ataxia, psychosis, coma, tachycardia, mydriasis, restlessness, urinary retention, disturbed speech and swallowing [2]. Atropine poisoning can be fatal due to respiratory depression and cardiac arrhythmia.

The purpose of this communication is to:

  • inform you of these recent detections of atropine in cocaine and ketamine samples in the Netherlands;
  • highlight that suspected poisonings and detections in urine samples have also been reported;
  • highlight that there is a potential for severe toxicity with atropine;
  • request that you report any recent detections of atropine as soon as possible to the Belgian Early Warning System drugs using bewsd@wiv-isp.be.
  
06/12/2017 22:55
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) just released the report on the formal risk assessment for furanylfentanyl.

This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), 
carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. 

On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 15 November 2017, 
the Council decided that furanylfentanyl should be subject to control measures across the Member States.

The entire risk assessment report can be downloaded in pdf format​.
  
22/11/2017 13:32
The U.S. Drug Enforcement Administration has issued the following notice of intent:
 
  
13/06/2017 14:57
The 2017 European Drug Report was launched at the beginning of June. 

It can be found here​.

The report provides an overview of the drug situation in Europe, for every single country.
This was accompanied for the first time by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway).

The country drug report for Belgium can be found on the EMCDDA website.
  
13/06/2017 15:03


The EMCDDA ​has released its report on high-risk drug use and new psychoactive substances (NPS).

This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, 
including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with men. 
It explores, in particular, the use of synthetic cathinones, synthetic cannabinoids and new synthetic opioids, as well as related harms and responses.

This important publication can be downloaded in English on this location.

  
17/03/2017 11:39

At their recently concluded meeting in Vienna, the Commission on Narcotic Drugs, an organization under the United Nationshas decided to place ten Novel Psychoactive Substances under international control.

More information can be found here. The substances are:  

·         U-47700 - Schedule I
       ·         Butyrfentanyl- Schedule I
       ·         4-Methylethcathinone (4-MEC) - Schedule II
       ·         Ethylone - Schedule II
       ·         Pentedrone (α-Methylaminovalerophenone) - Schedule II
       ·         Ethylphenidate (EPH) - Schedule II
       ·         Methiopropamine (MPA) - Schedule II
       ·         MDMB-CHMICA - Schedule II
       ·         5F-APINACA (5F-AKB-48) - Schedule II
       ·         XLR-11 - Schedule II
  
06/03/2017 16:24
  
01/03/2017 13:14

March 1, 2017 - A New Psychoactive Substances Act entered into force in Germany on 26 November 2016, controlling specific new psychoactive substances (NPS).

Under the new act, NPS are defined as any substance or preparation belonging to the specified generic (group) definitions for synthetic cannabinoids and compounds derived from 2-phenylethylamine.

The new act prohibits producing, trading, importing, offering and possessing NPS and empowers police and customs services to confiscate substances using their general powers to protect life and health.

The text can be found here.

 
  
01/03/2017 12:10

March 1, 2017 - The EU reacted to serious concerns over the use of the synthetic cannabinoid MDMB-CHMICA by deciding to subject it to ‘control measures’ on February 27th, 2017.

The substance in question has been raising health concerns in Europe after harmful effects related to its use were reported by the Member States through the EU Early Warning System, coordinated by the EMCDDA.

Consumption of DMB-CHMICA resulted in dozens of deaths and intoxications throughout Europe during the summer of 2015.

During the risk assessment, which was held in July 2016, the EMCDDA scientific committee concluded that the potency of MDMB-CHMICA and the highly variable amounts of the compound encountered in herbal products constitute a  serious risk of acute toxicity.

The risk assessment full text can be found on the website of the EU Council.

  
23/02/2017 13:36
The Eu​​​ropean Monitoring Center for Drugs and Drug Addiction (EMCDDA)​ has released its EMCDDA-Europol Joint Report on the new psychoactive substance acroylfentanyl. Acroylfentanyl is a potent NPS opioid which has surfaced in Europe in 2016. The document can be downloaded here.
1 - 10Next

Welcome to your site!

 

Add a new image, change this welcome text or add new lists to this page by clicking the edit button above. You can click on Shared Documents to add files or on the calendar to create new team events. Use the links in the getting started section to share your site and customize its look.